Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salivary Testosterone for Doping Control Screening
NCT02134470Unknown
- Sponsor
- Paracelsus Medical University
- Start
- Apr 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of testosterone in Hypogonadism, sponsored by Paracelsus Medical University. Primary endpoint: Salivary testosterone concentration at 2 weeks. Status: unknown.
02
Drugs
testosterone
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT02134470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02134470.